[HTML][HTML] Amyloid precursor protein and endosomal–lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease

RA Nixon - The FASEB Journal, 2017 - ncbi.nlm.nih.gov
Abnormalities of the endosomal–lysosomal network (ELN) are a signature feature of
Alzheimer's disease (AD). These include the earliest known cytopathology that is specific to …

Liver X receptors in lipid metabolism: opportunities for drug discovery

C Hong, P Tontonoz - Nature reviews Drug discovery, 2014 - nature.com
The liver X receptors (LXRs) are pivotal regulators of lipid homeostasis in mammals. These
transcription factors control the expression of a battery of genes involved in the uptake …

Detecting epistasis in human complex traits

WH Wei, G Hemani, CS Haley - Nature Reviews Genetics, 2014 - nature.com
Genome-wide association studies (GWASs) have become the focus of the statistical analysis
of complex traits in humans, successfully shedding light on several aspects of genetic …

Apolipoprotein E in Alzheimer's disease: an update

JT Yu, L Tan, J Hardy - Annual review of neuroscience, 2014 - annualreviews.org
The vast majority of Alzheimer's disease (AD) cases are late onset (LOAD), which is
genetically complex with heritability estimates up to 80%. Apolipoprotein E (APOE) has been …

iPS cells: a game changer for future medicine

H Inoue, N Nagata, H Kurokawa, S Yamanaka - The EMBO journal, 2014 - embopress.org
The induced pluripotent stem cell (i PSC) technology is instrumental in advancing the fields
of disease modeling and cell transplantation. We herein discuss the various issues …

[HTML][HTML] Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans

AJ Saykin, L Shen, X Yao, S Kim, K Nho… - Alzheimer's & …, 2015 - Elsevier
Introduction Genetic data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) have
been crucial in advancing the understanding of Alzheimer's disease (AD) pathophysiology …

Synthesis and preclinical evaluation of 11C-UCB-J as a PET tracer for imaging the synaptic vesicle glycoprotein 2A in the brain

NB Nabulsi, J Mercier, D Holden, S Carré… - Journal of Nuclear …, 2016 - Soc Nuclear Med
The synaptic vesicle glycoprotein 2A (SV2A) is found in secretory vesicles in neurons and
endocrine cells. PET with a selective SV2A radiotracer will allow characterization of drugs …

Machine learning and big data: Implications for disease modeling and therapeutic discovery in psychiatry

AMY Tai, A Albuquerque, NE Carmona… - Artificial intelligence in …, 2019 - Elsevier
Introduction Machine learning capability holds promise to inform disease models, the
discovery and development of novel disease modifying therapeutics and prevention …

[HTML][HTML] Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task …

A Bakker, MS Albert, G Krauss, CL Speck… - NeuroImage: Clinical, 2015 - Elsevier
Studies of individuals with amnestic mild cognitive impairment (aMCI) have detected
hyperactivity in the hippocampus during task-related functional magnetic resonance imaging …

Quercetin is an active agent in berries against neurodegenerative diseases progression through modulation of Nrf2/HO1

AB Bayazid, BO Lim - Nutrients, 2022 - mdpi.com
Berries are well-known fruits for their antioxidant effects due to their high content of
flavonoids, and quercetin is one of the potent bioactive flavonoids. Although oxidative stress …